5-HT4 antagonism in irritable bowel syndrome (IBS):: Effect of SB-207266-A on rectal sensitivity and small bowel transit.

被引：0

作者：

Houghton, LA

Jackson, NA

Whorwell, PJ

Cooper, S

机构：

[1] SmithKline Beecham Pharmaceut, Harlow CM19 5AW, Essex, England

[2] Univ S Manchester Hosp, Dept Med, Manchester M20 2LR, Lancs, England

来源：

GASTROENTEROLOGY | 1998年 / 114卷 / 04期

关键词：

D O I：

10.1016/S0016-5085(98)83139-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

G3164

引用

页码：A768 / A768

页数：1

共 50 条

[1] 5-HT4 receptor antagonism in irritable bowel syndrome:: effect of SB-207266-A on rectal sensitivity and small bowel transit
Houghton, LA
Jackson, NA
Whorwell, PJ
Cooper, SM
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (11) : 1437 - 1444
[2] 5HT(4) antagonism in irritable bowel syndrome (IBS): Effect of SB-207266-A on rectal sensitivity and small bowel transit
Houghton, LA
Jackson, NA
Whorwell, PJ
Cooper, S
GUT, 1997, 41 : A26 - A26
[3] Piboserod hydrochloride -: SB-207266A -: Treatment of IBS -: 5-HT4 antagonist
不详
DRUGS OF THE FUTURE, 2000, 25 (12) : 1323 - 1323
[4] Tegaserod, a 5-HT4 receptor partial agonist, relieves key symptoms of irritable bowel syndrome (IBS).
Mueller-Lissner, S
Fumagalli, I
Bardhan, KD
Pace, F
Nault, B
Pecher, EC
Rueegg, PC
Lefkowitz, MP
GASTROENTEROLOGY, 2000, 118 (04) : A175 - A175
[5] A pharmacodynamic model of 5-HT4 receptor activation in man: Antagonism by the 5-HT4 receptor antagonist SB-207266
Cooper, SM
Haydock, SF
Tompson, DJ
Higgins, RG
Fitzpatrick, KL
GASTROENTEROLOGY, 1999, 116 (04) : A598 - A598
[6] Nutrient-dependent enhancement of rectal sensitivity in irritable bowel syndrome (IBS)
Simren, M.
Agerforz, P.
Bjornsson, E. S.
Abrahamsson, H.
NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (01) : 20 - 29
[7] Rectal sensitivity and gastrointestinal symptom severity in irritable bowel syndrome (IBS): Is there a link?
Syrous, A
Lindstrom, L
Lindh, A
Bjornsson, E
Abrahamsson, H
Simren, M
GASTROENTEROLOGY, 2005, 128 (04) : A110 - A110
[8] Safety profile of tegaserod, a 5-HT4 receptor agonist, for the treatment of irritable bowel syndrome
Hasler, WL
Schoenfeld, P
DRUG SAFETY, 2004, 27 (09) : 619 - 631
[9] Tegaserod:: A novel, selective 5-HT4 receptor partial agonist for irritable bowel syndrome
Beglinger, C
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (01) : 47 - 51
[10] Safety Profile of Tegaserod, a 5-HT4 Receptor Agonist, for the Treatment of Irritable Bowel Syndrome
William L. Hasler
Philip Schoenfeld
Drug Safety, 2004, 27 : 619 - 631

← 1 2 3 4 5 →